![]() |
|
#1
|
|||
|
|||
|
FRANKFURT (Reuters) - German biotech Morphosys moved a step closer to getting its first antibody drug onto the market as its licensee, Johnson & Johnson unit Jenssen, reported positive results from a phase 3 study of psoriasis drug guselkumab. ??????? ??????: Morphosys moves closer to getting first antibody drug on market || ??????: ahlam1399 || ??????: اسم منتداك
|
![]() |
|
|